Recombinant Anti-CA19-9 x Anti-CD3 Bispecific Antibody (CrossMab)
TypeName: Business Offer
Category:
Offer Date:2019/05/24
Country: United States
Summary: Recombinant Anti-CA19-9 x Anti-CD3 Bispecific Antibody (CrossMab) is designed to be expressed as four chains with knobs-into-holes mutations and domain crossover. After one or multi-steps purification, high-purity antibody can be obtained. This BsAb can retarget T cells to tumor cells. It is designed for the research of Ovarian cancer; Pancreatic cancer; Gastric cancer therapy.https://www.creative-biolabs.com/bsab/symbolsearch-ca19-9%2520%2526%2520cd3.htm
Agriculture & Food
Business Services
Electronics, IT and Telecoms
Leisure & Tourism
Minerals
Textiles, Clothing, Leather,
Transport & Logistics
